Logo of The Journal of Bone & Joint Surgery (Br)
Quick search:        
          Advanced Search
Guest Access | Sign In
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campanacci, M
Right arrow Articles by Giunti, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campanacci, M
Right arrow Articles by Giunti, A
Journal of Bone and Joint Surgery - British Volume, Vol 62-B, Issue 1, 93-101
Copyright © 1980 by British Editorial Society of Bone and Joint Surgery


Articles

Multiple-drug chemotherapy for the primary treatment of osteosarcoma of the extremities

M Campanacci, G Bacci, P Pagani, and A Giunti

Fifty-five cases of osteosarcoma of the extremities were treated between 1972 and 1976 by combined surgery and chemotherapy (vincristine, adriamycin and methotrexate in medium doses) for 18 months. The follow-up ranges from 30 to 80 months (mean = 48 months). Twenty-six patients remained free from any evidence of disease, two had local recurrences but no metastases and 27 had metastases (four of these also had local recurrences). In 12 patients, the metastases appeared after the end of chemotherapy. Both metastases and local recurrences were more frequent in patients who had segmental bone resection (7/8) than in those treated by more radical surgery (22/47). Comparison with an "historical" group (94 osteosarcoma patients treated by operation alone in our Institute between 1960 and 1971) showed that the percentage of patients free from evidence of disease was higher in the group who receiving chemotherapy. In addition, the appearance of metastases in this group was delayed (mean = 16 months) as compared with the historical controls (mean = 8 months). On the other hand, after the same kind of operative treatment, the rate of local recurrences and the time of their appearance was almost identical in both groups.


This article has been cited by other articles:


Home page
J Bone Joint Surg BrHome page
L. M. Jeys, J. S. Luscombe, R. J. Grimer, A. Abudu, R. M. Tillman, and S. R. Carter
The risks and benefits of radiotherapy with massive endoprosthetic replacement
J Bone Joint Surg Br, October 1, 2007; 89-B(10): 1352 - 1355.
[Abstract] [Full Text] [PDF]



(c) British Editorial Society of Bone and Joint Surgery All Rights Reserved
Registered charity no: 209299     Print ISSN: 0301-620X
Hip, Knee, Trauma, Upper limb, Foot & Ankle, Paediatrics, Oncology, Spine, Arthroplasty, General